• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Aprotinin is a competitive inhibitor of the factor VIIa-tissue factor complex.

作者信息

Chabbat J, Porte P, Tellier M, Steinbuch M

机构信息

Centre National de Transfusion Sanguine, Paris, France.

出版信息

Thromb Res. 1993 Aug 1;71(3):205-15. doi: 10.1016/0049-3848(93)90095-6.

DOI:10.1016/0049-3848(93)90095-6
PMID:7692618
Abstract

A highly purified preparation of human plasma factor VIIa was submitted to chromogenic assays with S-2288 factors IXa, Xa, activated protein C and thrombin being absent. Factor VIIa alone or in the presence of calcium, kept its activity even in the presence of high concentrations of aprotinin, inhibition appeared only in the presence of a factor VIIa-tissue factor complex. A two-stage amidolytic assay using activation of purified factor X and hydrolysis of S-2765 chromogenic substrate by the generated Xa was used to show a competitive inhibition with a Ki value of 30 microM. Aprotinin had no effect on factor Xa amidolytic activity per se. The factor VIIa-tissue factor complex could be adsorbed to immobilized aprotinin and removed by a chaotropic ion like KSCN 3 M. The assays with the DFP inactivated VIIa-tissue factor complex proved that the interaction involved the active site of factor VIIa. The inhibition of the VIIa-tissue factor complex was demonstrated in a clotting assay using aprotinin enriched normal or factor VIII deficient plasma.

摘要

相似文献

1
Aprotinin is a competitive inhibitor of the factor VIIa-tissue factor complex.
Thromb Res. 1993 Aug 1;71(3):205-15. doi: 10.1016/0049-3848(93)90095-6.
2
Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.组织因子残基赖氨酸165和赖氨酸166对于组织因子-VIIa与Xa、组织因子途径抑制物的四元复合物的快速形成至关重要。
Biochemistry. 1995 Aug 29;34(34):10867-71. doi: 10.1021/bi00034a020.
3
Tissue factor-dependent autoactivation of human blood coagulation factor VII.人凝血因子VII的组织因子依赖性自身激活
J Biol Chem. 1992 Sep 25;267(27):19089-94.
4
Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.与经抑肽酶突变体抑制的因子VIIa复合的细胞外组织因子的结构
J Mol Biol. 1999 Feb 5;285(5):2089-104. doi: 10.1006/jmbi.1998.2452.
5
Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.磷脂通过底物和产物相互作用调节组织因子/因子VIIa(TF/VIIa)对因子X的激活。
Biochemistry. 2005 Jun 7;44(22):8187-97. doi: 10.1021/bi050338b.
6
Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.重组人外源性途径抑制剂。其对组织因子启动的凝血反应的抑制活性的产生、分离及特性研究。
J Biol Chem. 1990 Oct 5;265(28):16786-93.
7
Tissue factor pathway inhibitor: a possible mechanism of action.组织因子途径抑制剂:一种可能的作用机制。
Eur J Biochem. 2002 Apr;269(8):2016-31. doi: 10.1046/j.1432-1033.2002.02818.x.
8
Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.血友病作为凝血组织因子途径的缺陷:因子VIII和IX对连续流动反应器中因子X激活的影响。
Proc Natl Acad Sci U S A. 1990 Oct;87(19):7623-7. doi: 10.1073/pnas.87.19.7623.
9
Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.活性位点失活的凝血因子VIIa、Xa和IXa在组织因子启动的凝血细胞模型中抑制各个步骤。
Thromb Haemost. 1998 Oct;80(4):578-84.
10
Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol.
Blood Coagul Fibrinolysis. 1991 Jun;2(3):425-33.

引用本文的文献

1
Aprotinin Inhibits Thrombin Generation by Inhibition of the Intrinsic Pathway, but is not a Direct Thrombin Inhibitor.抑肽酶通过抑制内源性途径抑制凝血酶生成,但不是直接的凝血酶抑制剂。
TH Open. 2021 Aug 31;5(3):e363-e375. doi: 10.1055/s-0041-1735154. eCollection 2021 Jul.
2
A Kunitz-type peptide from venom as a simultaneous inhibitor of serine and cysteine proteases.一种来自毒液的Kunitz型肽,可同时抑制丝氨酸蛋白酶和半胱氨酸蛋白酶。
J Venom Anim Toxins Incl Trop Dis. 2020 Oct 7;26:e20200037. doi: 10.1590/1678-9199-JVATITD-2020-0037. eCollection 2020.
3
Perioperative management of aspirin resistance after off-pump coronary artery bypass grafting: possible role for aprotinin.
非体外循环冠状动脉旁路移植术后阿司匹林抵抗的围手术期管理:抑肽酶的可能作用
Transfusion. 2008 Mar;48(1 Suppl):39S-46S. doi: 10.1111/j.1537-2995.2007.01575.x.
4
A risk-benefit assessment of aprotinin in cardiac surgical procedures.心脏手术中抑肽酶的风险效益评估。
Drug Saf. 1998 Jan;18(1):21-41. doi: 10.2165/00002018-199818010-00003.